Kvinner og kreft publikasjoner
2023
Ahimbisibwe A, Valberg M, Green AC, Ghiasvand R, Rueegg CS, Rimal R, Weiderpass E, Sandanger TM, Robsahm TE, Veierød MB.
Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick.
Chen SLF, Nøst TH, Botteri E, Ferrari P, Braaten T, Sandanger TM, Borch KB.
Overall lifestyle changes in adulthood are associated with cancer incidence in the Norwegian Women and Cancer Study (NOWAC) - a prospective cohort study.
Delgado AB, Tylden ES, Lukic M, Moi L, Busund LR, Lund E, Olsen KS.
Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study.
Gjersvik, P.
Usunne solvaner, mer hudkreft.
Krum-Hansen S, Olsen KS, Anderssen E, Frantzen JO, Lund E, Paulssen RH.
Associations of breast cancer related exposures and gene expression profiles in normal breast tissue-The Norwegian Women and Cancer normal breast tissue study.
Lukic M, Licaj I, Laaksonen MA, Weiderpass E, Borch KB, Rylander C.
The burden of colon cancer attributable to modifiable factors-The Norwegian Women and Cancer Study.
Nøst TH, Skogholt AH, Urbarova I, Mjelle R, Paulsen EE, Dønnem T, Andersen S, Markaki Maria, Røe OD, Johansson M.
Increased levels of microRNA‐320 in blood serum and plasma is associated with imminent and advanced lung cancer.
Paulsen EM, Rylander C, Brustad M, Jensen TE.
Pre-diagnostic intake of vitamin D and incidence of colorectal cancer by anatomical subsites: the Norwegian Women and Cancer Cohort Study (NOWAC).
2022
Gram IT, Wiik AB, Lund E, Licaj I, Braaten T.
Never-smokers and the fraction of breast cancer attributable to second-hand smoke from parents during childhood: the Norwegian Women and Cancer Study 1991-2018.
Jensen TME, Braaten T, Jacobsen BK, Skeie G.
Non-linear associations between healthy Nordic foods and all-cause mortality in the NOWAC study: a prospective study.
Lergenmuller S, Ghiasvand R, Robsahm TE, Green AC, Lund E, Rueegg CS, Veierød MB.
Sunscreens With High Versus Low Sun Protection Factor and Cutaneous Squamous Cell Carcinoma Risk: A Population-Based Cohort Study.
Lergenmuller S, Rueegg CS, Perrier F, Robsahm TE, Green AC, Lund E, Ghiasvand R, Veierød MB.
Lifetime Sunburn Trajectories and Associated Risks of Cutaneous Melanoma and Squamous Cell Carcinoma Among a Cohort of Norwegian Women.
Fredriksen JMM, Mols R, Skeie G.
Klassifisering av ultraprossessert mat i Kvinner og kreft-studien: Et sommerprosjekt.
Page CM, Nøst TH, Djordjilović V, Thoresen M, Frigessi A, Sandanger TM, Veierød MB.
Pre-diagnostic DNA methylation in blood leucocytes in cutaneous melanoma; a nested case-control study within the Norwegian Women and Cancer cohort.
Perrier F, Ghiasvand R, Lergenmuller S, Robsahm TE, Green AC, Borch KB, Sandanger TM, Weiderpass E, Rueegg CS, Veierød MB.
Life-Course Trajectories of Physical Activity and Melanoma Risk in a Large Cohort of Norwegian Women.
Waaseth M, Havelkova M, Forsdahl G, Lund E, Log T.
Use of Selective Serotonin Reuptake Inhibitors - Validity of Self-Report versus Plasma Concentrations and Pharmacy Dispensations - A Cross-Sectional Analysis of the Norwegian Women and Cancer Study.
2021
Alvarez A, Borch KB, Rylander C.
Reproductive Factors, Use of Exogenous Hormones, and Pancreatic Cancer Incidence: The Norwegian Women and Cancer Study.
Baiju N, Sandanger TM, Sætrom P, Nøst TH.
Gene expression in blood reflects smoking exposure among cancer-free women in the Norwegian Women and Cancer (NOWAC) postgenome cohort.
Chen SLF, Braaten T, Borch KB, Ferrari P, Sandanger TM, Nøst TH.
Combined Lifestyle Behaviors and the Incidence of Common Cancer Types in the Norwegian Women and Cancer Study (NOWAC).
da Silva M, Laaksonen MA, Lissner L, Weiderpass E, Rylander C.
Preventable fractions of cancer incidence attributable to 7-years weight gain in the Norwegian Women and Cancer (NOWAC) study.
Ghiasvand R, Green AC, Sandanger TM, Weiderpass E, Robsahm TE, Veierød MB.
Phenotypic Characteristics and Melanoma Thickness in Women.
Hansen MS, Licaj I, Braaten T, Lund E, Gram IT.
The fraction of lung cancer attributable to smoking in the Norwegian Women and Cancer (NOWAC) Study.
Jareid M, Snapkov I, Holden M, Busund LR, Lund E, Nøst TH.
The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort.
Nøst TH, Holden M, Dønnem T, Bøvelstad H, Rylander C, Lund E, Sandanger TM.
Transcriptomic signals in blood prior to lung cancer focusing on time to diagnosis and metastasis.
Olsen KS, Holden M, Thalabard JC, Busund LTR, Lund E, Holden L.
Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort.
Perrier F, Ghiasvand R, Lergenmuller S, Robsahm TE, Green AC, Borch KB, Sandanger TM, Weiderpass E, Rueegg CS, Veierød MB.
Physical activity and cutaneous melanoma risk: A Norwegian population-based cohort study.
Ponzi E, Thoresen M, Nøst TH, Møllersen K.
Integrative, multi-omics, analysis of blood samples improves model predictions: applications to cancer.
Støer NC, Botteri E, Busund M, Ghiasvand R, Vangen S, Lund E, Weiderpass E, Veierød MB.
Menopausal hormone therapy and risk of melanoma: a population‐based cohort study.
2020
Busund LTR
Advancing Systems Epidemiology in Cancer: Exploring Trajectories of Gene Expression.
Charles D, Berg V, Nøst TH, Huber S, Sandanger TM, Rylander C.
Pre- and post-diagnostic blood profiles of perfluoroalkyl acids in type 2 diabetes mellitus cases and controls.
Fjukstad B, Shvetsov N, Nøst TH, Bøvelstad H, Halbach T, Holsbø E, Hansen K, Bongo LA.
Reproducible data management and analysis using R.
Holsbø E, Møllersen K.
Woes of The Practicing Omics Researcher.
Holsbø E, Olsen KS.
Metastatic Breast Cancer and Pre-Diagnostic Blood Gene Expression Profiles-The Norwegian Women and Cancer (NOWAC) Post-Genome Cohort.
Holsbø E, Perduca V, Bongo LA, Lund E, Birmelé E.
Predicting breast cancer metastasis from whole-blood transcriptomic measurements.
Lukic M, Barnung RB, Skeie G, Olsen KS, Braaten T.
Coffee consumption and overall and cause-specific mortality: the Norwegian Women and Cancer Study (NOWAC).
Lund E, Holden M, Thalabard JC, Busund LTR, Snapkov I, Holden L.
Signals of Death—Post-Diagnostic Single Gene Expression Trajectories in Breast Cancer—A Proof of Concept.
Olsen KS, Lukic M, Borch KB.
Physical activity and blood gene expression profiles: the Norwegian Women and Cancer (NOWAC) Post-genome cohort.
Page CM, Djordjilović V, Nøst TH, Ghiasvand R, Sandanger TM, Frigessi A, Thoresen M, Veierød MB.
Lifetime Ultraviolet Radiation Exposure and DNA Methylation in Blood Leukocytes: The Norwegian Women and Cancer Study.
Sollberger TL, Gavrilyuk O, Rylander C.
Excess Body Weight and Incidence of Type 1 and Type 2 Endometrial Cancer: The Norwegian Women and Cancer Study.
2019
Barnung RB, Jareid M, Lukic M, Oyeyemi SO, Rudolfsen JH, Sovershaeva E, Skeie G.
High lactose whey cheese consumption and risk of colorectal cancer - The Norwegian Women and Cancer Study.
Borch KB, Weiderpass E, Braaten T, Hansen MS, Licaj I.
Risk of lung cancer and physical activity by smoking status and body mass index, the Norwegian Women and Cancer Study.
Ghiasvand R, Robsahm TE, Green AC, Rueegg CS, Weiderpass E, Lund E, Veierød MB.
Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
Lergenmuller S, Ghiasvand R, Robsahm TE, Green AC, Lund E, Rueegg CS, Veierød MB.
Association of Lifetime Indoor Tanning and Subsequent Risk of Cutaneous Squamous Cell Carcinoma.
Moi l, Braaten T, Al-Shibli K, Lund E, Busund LR.
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Oyeyemi SO, Braaten T, Botteri E, Berstad P, Borch KB.
Exploring geographical differences in the incidence of colorectal cancer in the Norwegian Women and Cancer Study: a population-based prospective study.
Oyeyemi SO, Braaten T, Skeie G, Borch KB.
Competing mortality risks analysis of prediagnostic lifestyle and dietary factors in colorectal cancer survival: the Norwegian Women and Cancer Study.
Rylander C, Veierød MB, Weiderpass E, Lund E, Sandanger TM.
Use of skincare products and risk of cancer of the breast and endometrium: a prospective cohort study.
Sigstad Lande M, Rosenvinge JH, Skeie G, Rylander C.
Prevalence and correlates of self-reported disordered eating: A cross-sectional study among 90 592 middle-aged Norwegian women.
Støer NC, Botteri E, Ghiasvand R, Busund M, Vangen S, Lund E, Veierød MB, Weiderpass E.
Reproductive factors and risk of melanoma: a population-based cohort study.
Waaseth M, Larsen HN, Thoresen MBS, Skeie G.
Bruk av kosttilskudd blant middelaldrende norske kvinner.
2018
Bakken T, Braaten T, Olsen A, Hjartåker A, Lund E, Skeie G.
Milk and risk of colorectal, colon and rectal cancer in the Norwegian Women and Cancer (NOWAC) Cohort Study.
Barnung RB, Nøst TH, Ulven SM, Skeie G, Olsen KS.
Coffee Consumption and Whole-Blood Gene Expression in the Norwegian Women and Cancer Post-Genome Cohort.
Berg V, Nøst TH, Sandanger TM, Rylander C.
Predicting human plasma concentrations of persistent organic pollutants from dietary intake and socio-demographic information in the Norwegian Women and Cancer study.
Busund M, Bugge NS, Braaten T, Waaseth M, Rylander C, Lund E.
Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
da Silva M, Weiderpass E, Licaj I, Lissner L, Rylander C.
Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study.
da Silva M, Weiderpass E, Licaj I, Rylander C.
Factors Associated with High Weight Gain and Obesity Duration: The Norwegian Women and Cancer (NOWAC) Study.
Gavrilyuk O, Braaten T, Weiderpass E, Licaj I, Lund E.
Lifetime number of years of menstruation as a risk index for postmenopausal endometrial cancer in the Norwegian Women and Cancer Study.
Jareid M, Thalabard JC, Aarflot M, Bøvelstad HM, Lund E, Braaten T.
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Jensen TME, Braaten T, Jacobsen BK,Barnung RB, Olsen A, Skeie G.
Adherence to the Healthy Nordic Food Index in the Norwegian Women and Cancer (NOWAC) cohort.
Lukic M, Nilsson LM, Skeie G, Lindahl B, Braaten T.
Coffee consumption and risk of rare cancers in Scandinavian countries.
Lund E, Busund LTR, Thalabard JC.
Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft.
Lund E, Nakamura A, Snapkov I, Thalabard JC, Olsen KS, Holden L, Holden M.
Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients.
Lund E, Nakamura A, Thalabard JC.
No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
Oyeyemi SO, Braaten T, Licaj I, Lund E, Benjaminsen KB.
Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: a population-based prospective study.
Sandanger TM, Nøst TH, Guida F, Rylander C, Campanella G, Muller DC, van Dongen J, Boomsma DI, Johansson M, Vineis P, Vermeulen R, Lund E, Chadeau-Hyam M.
DNA methylation and associated gene expression in blood prior to lung cancer diagnosis in the Norwegian Women and Cancer cohort.
2017
Arnesen E.
Bruk av kosttilskudd og legemidler hos en gruppe personer over 50 år.
Attah AO, Braaten T, Skeie G.
Change in potato consumption among Norwegian women 1998-2005-The Norwegian Women and Cancer study (NOWAC).
Borch KB, Weiderpass E, Braaten T, Jareid M, Gavrilyuk O, Licaj IA.
Physical activity and risk of endometrial cancer in the Norwegian Women and Cancer (NOWAC) study.
Ghiasvand R, Rueegg CS, Weiderpass E, Green AC, Lund E, Veierød MB.
Indoor Tanning and Melanoma Risk: Long-Term Evidence From a Prospective Population-Based Cohort Study.
Jareid M, Licaj I, Standahl Olsen K, Lund E, Bøvelstad HM.
Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study.
Johannessen C, Moi L, Kiselev Y, Pedersen MI, Dalen SM, Braaten T, Busund LT.
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
Åsli LA, Olsen A, Braaten T, Lund E, Skeie G.
Potato Consumption and Risk of Colorectal Cancer in the Norwegian Women and Cancer Cohort.
2016
Gram IT, Little MA, Lund E, Braaten T.
The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012. British Journal of Cancer (2016) 115, 616–623.
2013
Gram IT, Sandin S, Braaten T, Lund E, Weiderpass E.
The hazards of death by smoking in middle-aged women. Eur J Epidemiol (2013) 28:799–806.
2012
Borch K B, Ekelund U, Brage S, Lund E.
Criterion validity of a 10-category scale for ranking physical activity in Norwegian women. Int J Behav Nutr Phys Act 2012 9:2.
Hansen L, et al.
Intake of dietary fiber, especially from cereal foods, is associated with lower incidence of colon cancer in the HELGA cohort.” Int J Cancer 2012 131(2):469-478.
Kyro C, et al.
Intake of whole grain in Scandinavia: intake, sources and compliance with new national recommendations. Scand J Public Health 2012 40(1):76-84.
Lund E, Plancade S.
Transcriptional output in a prospective design conditionally on follow-up and exposure: the multistage model of cancer. Int J Mol Epidemiol Genet 2012 3(2):107-114.
Rylander C, Lund E, Frøyland L, Sandanger T M.
Predictors of PCP, OH-PCBs, PCBs and chlorinated pesticides in a general female Norwegian population. Environ Int 2012 43:13-20.
Sæther S, Bakken K, Lund E.
The risk of breast cancer linked to menopausal hormone therapy. Tidsskr Nor Laegeforen 2012 132(11):1330-1334.
2011
Borch K B, Braaten T, Lund E, Weiderpass E.
Physical activity and mortality among Norwegian women – the Norwegian Women and Cancer Study. Clin Epidemiol 2011 3:229-235.
Bøvelstad H M, Borgan Ø.
Assessment of evaluation criteria for survival prediction from genomic data. Biom J. 2011 53(2):202-16.
Edvardsen K, Veierød MB, Brustad M, Braaten T, Engelsen O, Lund E.
Vitamin D-effective solar UV radiation, dietary Vitamin D and breast cancer risk. Int J Cancer. 2011 128(6):1425-33.
Landmark-Høyvik H, Dumeaux V, Reinertsen KV, Edvardsen H, Fosså SD, Børresen-Dale AL.
Blood gene expression profiling of breast cancer survivors experiencing fibrosis. Int J Radiat Oncol Biol Phys 2011 79(3):875-83.
Lund E.
An exposure driven functional model of carcinogenesis. Med Hypothesis 2011 77(2):195-8.
Rylander C, Dumeaux V, Olsen K S, Waaseth M, Sandanger T M, Lund E.
Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs in humans: the NOWAC postgenome study. Int J Mol Epidemiol Genet. 2011 2(3):207-16.
Sandanger T M, et al.
Plasma concentrations of parabens in postmenopausal women and self-reported use of personal care products: the NOWAC postgenome study. J Expo Sci Environ Epidemiol 2011.
Waaseth M, Olsen K S, Rylander C, Lund E, Dumeaux V.
Sex hormones and gene expression signatures in peripheral blood from postmenopausal women – the NOWAC postgenome study. BMC Medical Genomics 2011; 4:29.
2010
Dumeaux V, Olsen SK, Nuel G, Paulssen RH, Børresen-Dale AL, Lund E.
Deciphering blood gene expression variation – The postgenome NOWAC study. PLoS Genetics 2010 6(3).
Hjartåker A, Thoresen M, Engeset D, Lund E.
Dairy consumption and calcium intake and risk of breast cancer in a prospective cohort: the Norwegian Women and Cancer study. Cancer Causes Control. 2010 21(11):1875-85.
Lund E and Dumeaux, V.
Towards a more functional concept of causality in cancer research. Int J Mol Epidemiol Genet 2010; 1(2):124–133.
Rylander C, Sandanger T M, Frøyland L, Lund E.
Dietary patterns and plasma concentrations of perfluorinated compounds in 315 Norwegian women: the NOWAC Postgenome Study. Environ Sci Technol. 2010 44(13):5225-32.
Veierød M B, Adami H O, Lund E, Armstrong B K, Weiderpass E.
Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev. 2010 19(1):111-20.
Veierød M B, Smedby K E, Lund E, Adami H O, Weiderpass E.
Pigmentary characteristics, UV radiation exposure, and risk of non-Hodgkin lymphoma: a prospective study among Scandinavian women. Cancer Epidemiol Biomarkers Prev. 2010 19(6):1569-76.
Waaseth M, Nakling M, Bakken K, Grimsgaard S.
Use of dietary supplements and medication among postmenopausal women with vasomotor symptoms. Climacteric 2010 13(6):585-93.
2009
Barutcuoglu Z, Airoldi E M, Dumeaux V, Schapire R E, Troyanskaya O G.
Aneuploidy prediction and tumor classification with heterogeneous hidden conditional random fields. Bioinformatics 2009 25(10):1307-1313.
Braaten T, Weiderpass E, Lund E.
Socioeconomic differences in cancer survival: the Norwegian Women and Cancer Study. BMC Public Health 2009 9:178.
Engeset D, Dyachenko A, Ciampi A, Lund E.
Dietary patterns and risk of cancer of various sites in the Norwegian European Prospective Investigation into Cancer and Nutrition cohort: the Norwegian Women and Cancer study. Eur J Cancer Prev. 2009 18(1):69-75.
Gram I T, Braaten T, Lund E, Le Marchand L, Weiderpass E.
Cigarette smoking and risk of colorectal cancer among Norwegian women. Cancer Causes Control. 2009 20(6):895-903.
Landmark-Høyvik H, Reinertsen K V, Loge J H, Fosså S D, Børresen-Dale A L, Dumeaux V.
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics 2009 9(5):333-40.
Lönneborg A, Aarøe J, Dumeaux V, Børresen-Dale A L.
Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer. Expert Review of Anticancer Therapy 2009 9(8):1115-23.
Nielsen L B, Lund E.
Scientific misconduct and participation rates in population-based epidemiological research: the NOWAC study. Eur J Epidemiol. 2009 24(2):69-72.
Parr C L, Hjartåker A, Laake P, Lund E, Veierød M B.
Recall bias in melanoma risk factors and measurements error effects: a nested case-control study within the Norwegian Women and Cancer Study. Am J Epidemiol. 2009 169(3):257-66.
Skeie G, Braaten T, Hjartåker A, Brustad M, Lund E.
Cod liver oil, other dietary supplements and survival among cancer patients with solid tumours. Int J Cancer. 2009 125(5):1155-60.
Skeie G, Hjartåker A, Braaten T, Lund E.
Dietary change among breast and colorectal survivors and cancer-free women in the Norwegian Women and Cancer cohort study. Cancer Causes Control. 2009 20(10):1955-66.
Veierød M B, Parr C L, Lund E, Hjartåker A.
Response: errors in assessing risk factors for melanoma. Melanoma research. 2009 19(1):61.
Waaseth M, Bakken K, Lund E.
Patterns of hormone therapy use in the Norwegian Women and Cancer study (NOWAC) 1996-2005. Maturitas. 2009 63(3):220-6.
2008
Cox D G, et al. (Breast and Prostate Cancer Cohort Consortium)
Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer. 2008 122(2):387-92.
Dumeaux V, Børresen-Dale A L, Frantzen J O, Kumle M, Kristensen V N, Lund E.
Gene expression analyses in breast cancer epidemiology: the Norwegian Women and cancer postgenome cohort study. Breast Cancer Res. 2008 10(1):R13.
Gram I T, Braaten T, Adami H O, Lund E, Weiderpass E.
Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 2008 122:647-52.
Parr C L, Hjartåker A, Scheel I, Lund E, Laake P, Veierød M B.
Comparing methods for handling missing values in food-frequency questionnaires and proposing k nearest neighbours imputation: effects on dietary intake in the Norwegian Women and Cancer study (NOWAC). Public Health Nutr. 2008 11(4):361-70.
Veierød M B, et al.
Reproducibility of self-reported melanoma risk factors in a large cohort study of Norwegian women. Melanoma Research 2008 18(1):1-9.
Waaseth M, Bakken K, Dumeaux V, Olsen K S, Rylander C, Figenschau Y, Lund E.
Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort – a cross-sectional analysis. BMC Womens Health. 2008 8(1):1.
2007
Brustad M, Sandanger T M, Andersen V, Lund E.
POP exposure from fish liver consumption and risk of cancer–the Norwegian Women and Cancer Study. J Environ Monit. 2007 9(7):682-6.
Engeset D, Andersen V, Hjartåker A, Lund E.
Consumption of fish and risk of colon cancer in the Norwegian Women and Cancer (NOWAC) study. British Journal of Nutrition 2007 98, 576-582.
Hjartåker A, Andersen L F, Lund E.
Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study. Public Health Nutrition 2007, 10: 1094-1103.
Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M.
Hormone replacement therapy and breast cancer in former users of oral contraceptives – The Norwegian Women and Cancer study. Int J Cancer 2007 121(3):645-8.
2006
Dalen I, Buonaccorsi J P, Laake P, Hjartåker A, Thoresen M.
Regression analysis with categorized regression calibrated exposure: some interesting findings. Emerging Themes in Epidemiology 2006, 3:6.
Dumeaux V, Johansen J, Borresen-Dale A L, Lund E.
Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. Mol Cancer Ther. 2006 5(4):868-76.
Parr C L, Veierød M B, Laake P, Lund E, Hjartåker A.
Test-retest reproducibility of a food frequency questionnaire (FFQ) and estimated effects on disease risk in the Norwegian Women and Cancer Study (NOWAC). Nutr J. 2006;5:4.
Skeie G, Hjartaker A, Lund E.
Diet among breast cancer survivors and healthy women. The Norwegian Women and Cancer Study. Eur J Clin Nutr. 2006 60(9):1046-54.
Weiderpass E, et al.
Prospective study of physical activity in different periods of life and risk of ovarian cancer. Int J Cancer. 2006 118(12):3153-60.
2005
Bakken K, Alsaker E, Eggen A E, Lund E.
Impact of hormone replacement therapy (HRT) on incidence of breast cancer in Norway – the NOWAC study. Tidsskr Nor Laegeforen 2005 125:282-5.
Braaten T, Weiderpass E, Kumle M, Lund E.
Explaining the socioeconomic variation in cancer risk in the Norwegian Women and Cancer Study. Cancer Epidemiol Biomarkers Prev 2005 14(11 Pt 1):2591-2597.
Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F.
Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control. 2005 16(5):537-44.
Engeset D, Alsaker E, Ciampi A, Lund E.
Dietary patterns and lifestyle factors in the Norwegian EPIC cohort: the Norwegian Women and Cancer (NOWAC) study. Eur J Clin Nutr. 2005 59(5):675-84.
Hjartåker A, Adami H O, Lund E, Weiderpass E.
2004
Bakken K, Alsaker E, Eggen A E, Lund E.
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. Int J Cancer. 2004 112(1):130-4.
Bakken K, Eggen A E, Lund E.
Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstet Gynecol Scand. 2004 83(9):850-6.
Braaten T, Weiderpass E, Kumle M, Adami H O, Lund E.
Education and risk of breast cancer in the Norwegian-Swedish Women’s Lifestyle and Health cohort study. International Journal of Cancer 2004 110(4):579-83.
Brustad M, Alsaker E, Engelsen O, Aksnes L, Lund E.
Vitamin D status of middle-aged women at 65-71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutrition 2004 7(2):327-35.
Brustad M, Braaten T, Lund E.
Predictors for cod-liver oil supplement use – the Norwegian Women and Cancer Study. European Journal of Clinical Nutrition 2004 58(1):128-36.
Dumeaux V, Lund E, Hjartåker A.
Use of oral contraceptives, alcohol, and risk for invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2004 13(8):1302-7.
Kumle M, Weiderpass E, Alsaker E, Lund E.
Use of hormonal contraceptives and occurrence of pregnancy-related pelvic pain: a prospective cohort study in Norway. BMC Pregnancy Childbirth. 2004 4(1):11.
Kumle M, Weiderpass E, Braaten T, Adami H O, Lund E.
Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives. The Norwegian Swedish Women’s Lifestyle and Health Cohort Study. British Journal of Cancer 2004 90(7):1386-91.
Lund E, Engeset D, Alsaker E, Skeie G.
Comment: Cancer risk and salmon intake. The Norwegian Women and Cancer Study. Science 2004 305;477.
Trondsen T, Braaten T, Lund E, Eggen A E.
Health and seafood consumption patterns among women aged 45-69 years. A Norwegian seafood consumption study. Food Quality and Preference 2004 15(2):117-28.
Trondsen T, Braaten T, Lund E, Eggen A E.
Consumption of seafood—the influence of overweight and health beliefs. Food Quality and Preference 2004 15(4):361-74.
Weiderpass E, et al.
A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Epdiemiol Biomarkers Prev 2004 13(7):1-7.
2003
Bakken K, Eriksen A K, Eggen A E.
Estrogen therapy in menopause-attitudes and practices. Tidsskr.Nor Laegeforen. 2003 123(1):18-21.
Brustad M, Skeie G, Braaten T, Slimani N, Lund E.
Comparison of telephone vs face-to-face interviews in the assessment of dietary intake by the 24 h recall EPIC SOFT program–the Norwegian calibration study. Eur J Clin Nutr. 2003 57(1):107-13.
Dumeaux V, Alsaker E, Lund E.
Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study. Int J Cancer. 2003 105(6):844-50.
Kumle M, Alsaker E, Lund E.
Use of oral contraceptives and risk of cancer, a cohort study. Tidsskr.Nor Laegeforen. 2003 123(12):1653-6.
Trondsen T, Scholderer J, Lund E, Eggen A E.
Perceived barriers to consumption of fish among Norwegian women. Appetite 2003 41(3):301-14.
2002
Kumle M, Weiderpass E, Braaten T, Persson I, Adami H O, Lund E.
Use of oral contraceptives and breast cancer risk in The Norwegian-Swedish Women’s lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev. 2002 11(11):1375-81.
2001
Bakken K, Eggen A E, Lund E.
Hormone replacement therapy in Norwegian women, 1996-1997. Maturitas 2001 40(2):131-141.
Hjartåker A, Laake P, Lund E.
Childhood and adult milk consumption and risk of premenopausal breast cancer in a cohort of 48,844 women in the Norwegian Women and Cancer Study. Int J Cancer. 2001 93(6):888-93.
Hjartåker A, Laake P, Lund E.
Body mass index and weight change attempts among adult women The Norwegian Women and Cancer Study. Eur J Public Health 2001 11(2):141-146.
2000
Hjartåker A, Engeset D, Brustad M, Lund E.
Fiskekonsum og kreftrisiko blant norske kvinner – The Norwegian Women and Cancer Study (NOWAC). Norsk Epidemiologi 2000 10(1):63-70.
Myrland 0, Trondsen T, Johnston R, Lund E.
Determinants of seafood consumption characteristics in Norway; lifestyle, preferences and personal experiences. Food Qual Preferences 2000 11:169-88.
1998
Lund E, Gram I T.
Response rating according to title and length of questionnaire. Scand J Soc Med 1998 26(2):154-60.
Lund E, Kumle M, Sandaune A G.
Significance of migration patterns on self-evaluated health among Norwegian women aged 34-69 years. Tidsskrift for Norsk Lægeforening 1998 118:3752-5.
1997
Hjartåker A, Lund E, Bjerve K S.
Serumphospholipid fatty acid composition and habitual intake of marine foods registered by a comprehensive food frequency questionnaire. Eur J Clin Nutr 1997 51:736-42.
PhDer
Parr CL
Self-reported exposure data in epidemiologic studies: measurement errors and missing values
No. 616. Department of Biostatistics, Faculty of Medicine, University of Oslo 2008